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Blood Card and Vesicle-based  
Medical Tests 
All living cells produce extracellular vesicles 
(EVs), which are nano-sized compart-
ments. They are considered as a pivotal 
part of the intercellular environment and act 
as important players in cell-to-cell 
communication. The fact, that EVs are 
involved in the development and progress-
sion of several diseases, has formed the 
basis for the use of EV analyses in a clinical 
setting and envisions a great potential 
for using EVs as disease-related 
biomarkers. 
EVs are a heterogeneous population of 
membrane -enclosed vesicles that can be 
divided into a number of subpopulations 
based on specific characteristics such as 
size, biogenesis, cellular origin, protein 
composition, and biological function. The 
two major subtypes of EVs are exosomes 
and microvesicles. 
Extracellular Vesicles 
Venous blood is a convenient source of circulating extracellular vesicles (EVs). However, blood sampling 
requires authorized personnel and immediate purification of the vesicles. The present study demonstrate that 
intact EVs can in fact be obtained from dried blood card samples (or dried blood spots; DBS), which can be 
prepared by unauthorized personnel, or even at home by the user and shipped by regular mail. Intact EVs 
can be detected in extracts from dried blood spot samples even after prolonged storage. 
Being able to isolate and characterize small EVs from DBS opens up a number of new opportunities such as 
monitoring of disease, e.g. progression of cancer and response to treatment, only with involvement of a lab 
technician and responsible clinician. 
The qualitative tests revealed that, for most of 
the markers (11 out of 15), the samples from 
DBS showed similar results as for blood drawn 
using EDTA or CPDA collection tubes. After 21 
days of storage at room temperature, a 
higher degree of hemolysis were observed in 
the extracted samples (see top graph for Quality 
Control). The increase in free hemoglobin 
generated a higher background signal, but the 
samples were still acceptable for analysis with 
the EV Array. 
The analysis of small EVs carrying CD9 showed 
that all 20 persons were tested positive both 
with CPDA, EDTA and DBS. Furthermore, it was 
still possible to get a positive signal after 21 
days of storage at room temperature. For CD63, 
the responses from DBS were equal to EDTA 
plasma although a decrease were seen after 2 
weeks of storage. 
A refinement of the extraction procedure will be 
performed to obtain the most optimal condition 
for a future qualitative analysis of small EVs 
sampled as DBS. 
Storage Testing 
Blood samples for the dried blood cards was obtained from the fingertips of the donors using a 
lancet. The blood drops thoroughly saturated the paper (blood card especially designed for whole 
cells) and was allowed to air dry before storage and isolation of small EVs according to the 
protocol below. To evaluate the EV concentration and composition, the samples were analyzed 
using the EV Array (Jørgensen et al., 2013, JEV) using antibodies against 15 selected surface-
markers. This proof-of-concept study persisted of an experiment with blood from 20 healthy 
volunteers. The blood samples were used to test the effect of prolonged storage of the dried 
blood cards. The most optimal extraction procedure was used to compare the EV contents after 1 
hour, 7, 14 and 21 days after collection. 
General Protocol 
Development Phase / Current state 
A test setup with 20 subjects has proven that it is possible to measure vesicles from 
DBS, as a proof of concept. Several parameters can be optimized such as time, 
temperature, buffer and quantities. A series of optimization experiments must be 
performed with more donors before commercialization; this is estimated to take 2-3 
months without extensive costs. 
Technology Description / Technology Summary 
The proposed method is a combination of a known method for collecting blood samples used for more than 50 years, where samples are easily transported and stored as significantly less blood is required, 
with the EV Array, a new method for characterization of extracellular vesicles directly from plasma without purification requiring only 10 µL of sample. The EV Array is a protein-based microarray enabling 
classification of multiple surface markers simultaneously. 
Value proposition / USP 
The method is based on a combination of the dry blood sample (DBS) on a blood card and extracellular 
vesicle (EV) array. DBS is a minimally invasive and widespread method for collecting blood samples, where 
samples are transported, stored and processed easily. Combined with the EV Array´s ability to detect 
extracellular vesicles from unpurified blood makes this combination promising with regard to find biomarkers 
for cancer, inflammatory, metabolic, cardiovascular or neurodegenerative diseases. Another application is 
diagnosing, screening and monitoring of drug resistance, making drug trials cheaper, as less blood is needed. 
Business Opportunity / Objective / Commercial Perspectives 
DBS combined with the EV Array, utilizes a proven, cost-effective tool with a strong 
diagnostic tool making handling and processing of blood samples promising in developed 
and developing countries alike. The DBS-EV Array combination would reduce the cost of 
acquiring blood samples, and opens the possibility for development of home test kits. 
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More Information 
Detailed information about the 
technology can be found at: 
WWW.EVARRAY.DK 
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